On 28 July, BioPharmX Corporation (NYSEMKT:BPMX) declared that its product to address premenstrual breast discomfort, Violet® iodine, will soon be accessible through a wholly owned partner of The Kroger Co. (KR), the largest U.S. grocery retailer. BioPharmX Corporation (NYSEMKT:BPMX) belongs to Healthcare sector. Its weekly performance is -16.06%. On last trading day company shares ended up $1.83. BioPharmX Corporation (NYSEMKT:BPMX) distance from 50-day simple moving average (SMA50) is -32.35%.
On 30 July, Nobilis Health Corp. (NYSE: HLTH) has been approved to purchase Victory Plano Hospital LP for $5.8 million. The health care company purchased the Plano hospital with a cash payment of $1.3 million, the assumption of Plano’s loan with Legacy Bank of approximately $4.5 million and the assumption of Plano’s capital equipment and real estate leases. Nobilis Health Corp. (NYSEMKT:HLTH) shares fell -8.83% in last trading session and ended the day at $5.37. Nobilis Health Corp. (NYSEMKT:HLTH) quarterly performance is -22.17%.
Thomson Reuters Corporation (NYSE:TRI) has launched its new Corporate CPE Network subscription to help corporate professionals acquire up-to-date information, recommendations and best practices needed to understand, plan for, and implement new tax law and accounting requirements. On 07 August, Thomson Reuters Corporation (NYSE:TRI) shares fell -0.54% and was closed at $40.66. TRI EPS growth in last 5 year was 19.10%. Thomson Reuters Corporation (NYSE:TRI) year to date (YTD) performance is 2.50%.
Agnico Eagle Mines Ltd. (NYSE:AEM) on July 29 reported net income of US$10.1 million (US5 cents per share) for the second quarter of 2015, compared with net income of US$22.2 million (12 cents per share) for the same period last year. Cash provided by operating activities was US$188.3 million, up slightly from US$182.7 million provided by operating activities during the same period a year ago. Agnico Eagle Mines Limited (NYSE:AEM) ended the last trading day at $22.09. Company weekly volatility is calculated as 4.44% and price to cash ratio as 22.99. Agnico Eagle Mines Limited (NYSE:AEM) showed a weekly performance of -0.18%.
Pfizer Inc. (NYSE:PFE) has acquired the exclusive U.S. commercialization rights to Synthon’s potential generic version of glatiramer acetate (Copaxone, Teva Pharmaceuticals) for the treatment of relapsing–remitting multiple sclerosis (RRMS). On 07 August, Pfizer Inc. (NYSE:PFE) shares moved up 0.06% and was closed at $35.19. PFE EPS growth in last 5 year was 3.10%. Pfizer Inc. (NYSE:PFE) year to date (YTD) performance is 15.81%.